Literature DB >> 31186863

Natural history of nonalcoholic fatty liver disease.

Rohini Mehta1, Zobair M Younossi1,2.   

Abstract

Entities:  

Year:  2012        PMID： 31186863      PMCID： PMC6499274          DOI： 10.1002/cld.27

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  10 in total

1.  Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

Authors:  Maria Stepanova; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-13       Impact factor: 11.382

2.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

Authors:  Arun J Sanyal; Colin Banas; Carol Sargeant; Velimir A Luketic; Richard K Sterling; Richard T Stravitz; Mitchell L Shiffman; Douglas Heuman; Adrian Coterrell; Robert A Fisher; Melissa J Contos; Alan S Mills
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

4.  Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Paul Cheung-Lung Choi; Anthony Wing-Hung Chan; Mia Ka-Po Li; Hoi-Yun Chan; Angel Mei-Ling Chim; Jun Yu; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

5.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Elizabeth M Brunt; David E Kleiner; Kris V Kowdley; Naga Chalasani; Joel E Lavine; Vlad Ratziu; Arthur McCullough
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

7.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Authors:  Maria Stepanova; Nila Rafiq; Zobair M Younossi
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

8.  Long-term follow-up of patients with nonalcoholic fatty liver.

Authors:  Nila Rafiq; Chunhong Bai; Yun Fang; Manirath Srishord; Arthur McCullough; Terry Gramlich; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2008-11-07       Impact factor: 11.382

Review 9.  Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).

Authors:  Stefano Bellentani; Mariano Marino
Journal:  Ann Hepatol       Date:  2009       Impact factor: 2.400

10.  Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

Authors:  Janus P Ong; Angela Pitts; Zobair M Younossi
Journal:  J Hepatol       Date:  2008-07-09       Impact factor: 25.083
  10 in total
  1 in total

Review 1.  Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Authors:  Priyanka Bhandari; Amit Sapra; Mohitkumar S Ajmeri; Christine E Albers; Devanshika Sapra
Journal:  Cureus       Date:  2022-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.